Inspection Record

HUMN Pharmaceuticals Inc. — Health Canada Inspection Findings

Health CanadaInspected 2023-02-23 4 findingsQuality unit oversightStability and storageOther quality system

View the regulator's official source The source document is always the basis for judgement.

Findings

1Quality unit oversight

The quality control department did not evaluate the results of the annual product quality review.

2Stability and storage

The guidelines and/or procedures were inadequate in ensuring storage and/or transportation conditions would maintain the quality and safe distribution of the drug.

3Stability and storage

The ongoing stability program for a drug was inadequate.

4Other quality system

The assessment, documentation, and/or procedures for considering the resale of returned drugs were inadequate.

About this record

Extracted automatically from the document of the Health Canada inspection on 2023-02-23. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

2026-04-09 · Health Canada · 3 findings
HUMN Pharmaceuticals Inc. findings history — including this company's other documents Health Canada documents, 2023 Go to Findings search